Počet záznamov: 1
imunoterapia adoptívna
SYS d016219 LBL 00000cz--a2200000n--4500 005 20250606213024.6 008 920606|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 $d BA006 $d BA006 065 $a E02.095.465.425.400.330.050.400 065 $a E05.478.550.520.050.400 066 $a 01 $c 03 089 $a 615.37 $v UDC-MRF-SK3 $z slo 150 $a imunoterapia adoptívna $x AE $x CL $x EC $x ES $x HI $x IS $x LJ $x MO $x MT $x NU $x PX $x SN $x ST $x TD $x VE $2 slo 450 $w v $a Adoptive Cellular Immunotherapy $2 eng 450 $w v $a imunoterapia adoptívna bunková $2 slo 450 $w v $a imunoterapia CAR T-bunková $2 slo 450 $w v $a terapia chimérickým antigénovým receptorom $2 slo 550 $7 sllk_us_auth*d015979 $Y Killer Cells, Lymphokine-Activated $w b $a LAK bunky 550 $7 sllk_us_auth*d000076962 $Y Receptors, Chimeric Antigen $w p $a receptory antigénové chimérické 550 $7 sllk_us_auth*d016238 $Y Cytapheresis $w b $a cytaferéza 550 $7 sllk_us_auth*d016246 $Y Lymphocytes, Tumor-Infiltrating $w b $a lymfocyty infiltrujúce nádor 550 $7 sllk_us_auth*d016260 $Y Monocytes, Activated Killer $w b $a K monocyty aktivované 550 $7 sllk_us_auth*d000076962 $Y Receptors, Chimeric Antigen $w b $a receptory antigénové chimérické 665 $a 1991 $2 eng 665 $a Immunization, Passive (1983-1990) $2 eng 680 9-
$i Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314) $2 eng 680 $a for CAR T-Cell Therapy, coordinate with RECEPTORS, CHIMERIC ANTIGEN $2 eng 750 -2
$a Immunotherapy, Adoptive $2 eng 980 $x M
Počet záznamov: 1